Company / SG&A per Share
REGENXBIO Inc. SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.67
FY2025
5-year range
$1.38 / $2.04
FY2021-FY2025
Trend
-3.9%
vs FY2024
Sector context
#89 of 210
Health Care
What the data says
At $1.67, REGENXBIO Inc.'s sg&a per share ranks #122 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.15 in FY2016 to $2.04 in FY2023.
Based on SEC 10-K filings.
1.67 in FY2025 with a 5-year CAGR of +10.9%.
Improved from $2.04 to $1.67 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -5.6%
- 5-Year CAGR
- +10.9%
- 10-Year CAGR
- -
Sector benchmark
#122 of 210 in Health CareTop 58% of 210This company $1.67 Sector average $29.50
▼
-94.3% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 3.9% year-over-year.
- Ranks #89 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.67 | -3.9% |
| FY2024 | $1.74 | -14.9% |
| FY2023 | $2.04 | +2.6% |
| FY2022 | $1.99 | +44.0% |
| FY2021 | $1.38 | +38.8% |
| FY2020 | $1.00 | +32.1% |
| FY2019 | $0.75 | -36.0% |
| FY2018 | $1.18 | +14.5% |
| FY2017 | $1.03 | +602.7% |
| FY2016 | $0.15 | -92.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026